Dismissal of Prevagen case deals tough blow to FTC

(October 13, 2017) -- When the Federal Trade Commission and New York’s attorney general joined forces to sue Quincy Bioscience for deceptive advertising in promoting Prevagen, a dietary supplement, the enforcers came out guns blazing....

Related Sections